Pharmacological synergistic multi-target of Curcuma longa compounds to minimise the ototoxic effects and resistance of cisplatin in ovarian cancer treatment: integration of bibliometric analysis, pharmacological networking, and molecular docking approaches

compounds could enhance cisplatin's anticancer activity, reduce toxicity, and help overcome drug resistance in ovarian cancer therapy. The findings highlight the potential for natural, polyphenol-rich agents to complement chemotherapy and improve treatment outcomes.